Stomach Flu Remedies

A good dose of probiotics may help you overcome the symptoms of the problem. If you have a severe problem with abnormal symptoms, like, bloody stools or extremely high fever, you should immediately rush to your doctor.

. All these symptoms lead to dehydration, which makes the condition worse. Peculiar symptoms include, fever, cold sweats, vomiting, dizziness, nausea, diarrhea, etc. Thus, the treatment for stomach flu is mostly targeted at replenishing the loss of fluids due to vomiting and diarrhea.

The Remedies

Medications

Medications should be saved for the later stages of stomach flu. Also for kids, remedies are best prescribed by the pediatrician. However, before exploring them, let us have a good insight on what stomach flu really is.

Causes and Symptoms

Stomach flu or gastroenteritis is a viral infection of intestines. Incessant bathroom trips are bound to drain you up. Moreover, the loss of water makes you tired. Antibiotics worsen the condition by killing the good bacteria in the intestine. Though, it is not a cause of concern in most cases, the symptoms associated with it are absolutely awful. However, keep it light and free of fat. Sharing drinks and foods, eating with unwashed hands, are some of the modes of transmission of stomach flu virus. The infection spreads due to eating contaminated food or coming in contact with an infected person. Dairy products, raw foods, and foods containing tomato should be avoided for at least 10 days after the outbreak of the flu, as they tend to irritate the intestinal tract. Most people find it http://www.huffingtonpost.com/2013/02/27/zofran-pregnancy_n_2776753.html silly to call a doctor for a little bug that upsets their stomach. Solid foods should be avoided at any cost for at least first 24 hours. Avoid eating or drinking anything for the first 4 hours, this includes even water. Even the thought of frequent trips to the bathroom causes jitters in the stomach and makes stomach flu a scary disease. If you are attempting to treat yourself with over-the-counter medications, then steer clear of antibiotics or aspirin. Stomach flu is something that plagues most of us at some point of time. However, you may nibble some crackers or dry toast. Fortunately, there are myriad remedies, which can relieve you of this uncomfortable situation. The symptoms surface within 4 to 8 hours after the exposure to the virus. After that, depending upon your condition, you may switch to your normal, healthy diet.

The remedies listed in this article are only helpful for mild to moderate cases of stomach flu. Boiled rice, white bread, green bananas, etc., are light on stomach apart from being good remedies for the stomach problem. Once the symptoms appear to ease a little, you may slowly sip water, juice or any other clear liquid. However, if you do, your doctor is most likely to prescribe you anti-vomiting, anti-nauseating medications. Chicken broth, green tea, ginger ale, fruit gelatin, clear vegetable soup, are the best remedies during the first 24 hours.

Once your vomiting and diarrhea completely stops, it’s alright to switch to solid foods. It is a misnomer, as the virus causing this flu is different from influenza virus, which affects the respiratory system. However, before anything, you should try some natural remedies given below.

Home Remedies

Rest is the best remedy for stomach zofran birth defects intestine flu. Hence, as soon as the symptoms erupt, you should make it a point to lie down in bed

Can a patient sue a generic drug manufacturer?

All Rights Reserved. But the drug companies say that if the court rules for Bartlett, it going to cause the price of drugs to go up for everyone, especially if juries decide which drugs are safe and which aren’t. She said a ruling in her favor would force drug companies to make medications safer.

The generic drug caused her to lose the skin from 65 percent of her body. A ruling in the case is expected by July.

© 2013 CBS Interactive Inc.

“Federal law doesn’t permit a generic drug company to change either the design of its drug or the warning,” Lefkowitz told reporters.

The Obama administration is siding with the drug maker, arguing that the Food and Drug Administration had approved the medication as safe and the generic drug company Zofran lawsuit shouldn’t be responsible.

Several justices seemed to agree. They account for nearly 80 percent of the prescriptions written in this country– more than 3 billion every year. Today, Bartlett is legally blind and needs near-constant assistance. Justice Stephen Breyer said “what’s worrying me” is that a jury of “12 people instead of the FDA” could determine drug safety.

But Bartlett said her injuries are proof the drug should be off the market.

“When I dream, in my dreams, I can see perfectly and I can do whatever I want,” she said, “And then when I wake up, it’s a horrible reality check that I can’t.”

Bartlett is now 53 years old. For her, the hardest thing she’s dealing with is her loss of independence.

Before, Karen Bartlett was a vibrant woman who loved the outdoors (left).

(CBS News) WASHINGTON – Generic drugs are big business.

. “I can’t just jump in the car and go somewhere,” she told CBS News. “I just feel sometimes like a burden to people.”

Bartlett sued the manufacturer of the generic drug, Mutual Pharmaceutical, and a jury awarded her $21 million. But what happens when something goes wrong? Can the maker of a generic drug be sued when the FDA has declared the name-brand version safe? That was the question before the Supreme Court Tuesday.

Karen http://fdb.rxlist.com/drugs/drug-7758-Zofran+IV.aspx?drugid=7758&drugname=Zofran+IV Bartlett was an active, vibrant woman who loved the outdoors, and most of all spending time with her son Matt.

But in 2004, Bartlett, suffering shoulder pain, took an anti-inflammatory drug — known by its generic name as Sulindac — and suffered a rare allergic reaction so severe, her life, as she knew it, was over. But when she took a generic anti-inflammatory drug,she suffered a rare allergic reaction that left her to lose her skin from 65 percent of her body (left).

CBS News

But at the Supreme Court Tuesday, the company’s lawyer, Jay Lefkowitz, argued it can’t be held responsible since, by law, it was merely copying a brand-name drug. Mutual doesn’t dispute the drug caused her reaction

Zofran® Side Effects | Zofran Lawyer, Attorney

Metroclopramide, another anti-nausea drug sometimes used for morning sickness, was not associated with birth defects.

Interestingly, six months before this study was published, the New England Journal of Medicine published another study based on 600,000 births in Denmark that found no evidence of fetal harm. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments.

When used during pregnancy, the anti-nausea medication Zofran has been associated with birth defects, including heart defects and cleft palate. This can cause a loss of consciousness, low blood pressure, and sudden death.

FDA Warnings for Zofran Side Effects

The FDA first warned about Zofran side effects in September 2011. The taking zofran for morning sickness recall is unlikely to affect many patients because the dose makes up only a small percentage of the drug’s market.

Do I have a Zofran Lawsuit?

The Schmidt Firm, PLLC is currently accepting Zofran induced injury cases in all 50 states. It is also prescribed in lower doses to patients after surgery.

Zofran and Pregnancy

Zofran is commonly used “off-label” to prevent nausea and vomiting associated with morning sickness during the first trimester of pregnancy. Although animal studies found no evidence of pregnancy side effects, a growing number of population-based studies have found evidence linking Zofran and birth defects.

In August 2013, Zofran was linked to a 30% increased risk of birth defects and a doubled risk of heart defects in the study, “Ondansetron use in early pregnancy and the risk of congenital malformations.”.

Conclusions were based on data from nearly 900,000 pregnancies in Denmark between 1997 and 2010. The study was completed in June 2012, and found http://cancer.emedtv.com/zofran/zofran-side-effects.html that a single 32-mg dose of Zofran was associated with QT interval prolongation.

Serotonin Syndrome

March 2013 — The FDA has identified a “potential safety issue” about the risk of serotonin syndrome from Zofran and other drugs in the 5-HT3 class, which work by influencing serotonin levels. However, the study was too small to estimate the risk of individual birth defects with any precision.

Zofran Pregnancy Side Effects

Our attorneys are investigating cases involving:

Other pregnancy side effects of Zofran may include:

Fetal growth restriction (poor growth in the womb)

Jaundice

Kidney defects

Life-threatening complications for mother (serotonin syndrome, irregular heart rhythm, Torsade de Pointes, etc.)

Fetal or maternal death

Zofran Side Effects

Zofran is associated with life-threatening cardiac side effects. If you or somebody you know had a baby with a birth defect after using Zofran during pregnancy, you should contact our lawyers immediately for a free case consultation. The 32-mg dose of Zofran increases the QT interval by an average of 20 milliseconds, and the 8-mg dose is associated with a 6 millisecond change.

In severe cases, QT interval prolongation longer than 600 milliseconds can lead to Torsades de Pointes. Birth defects occurred in nearly 5% of the 1,250 women who used Zofran in the first trimester, compared to 3.5% of women who did not. It was approved in 1991 by the U.S. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.

What is Zofran?

Zofran (ondansetron) is an anti-nausea drug created by GlaxoSmithKline (GSK). The FDA has also issued safety warnings about deadly heart problems, including a deadly abnormal heart rhythm disorder called Torsade de Pointes.

What You Can Do How We Can Help

The Schmidt Firm, PLLC is currently accepting Zofran induced injury cases in all 50 states. The agency updated the label on Zofran to warn that it could increase the risk of “developing prolongation of the QT interval of the electrocardiogram, which can lead to an abnormal and potentially fatal heart rhythm, including Torsades de Pointes.”

After this warning, the FDA required the manufacturer to study what dose of Zofran was associated with cardiac risks. The risk of serotonin syndrome may be compounded in individuals who also use SSRI antidepressants, which also influence serotonin

Serotonin syndrome side effects:

Agitation or restlessness

Confusion

Rapid heartbeat and high blood pressure

Loss of muscle coordination, twitching or rigid muscles

Heavy sweating

Diarrhea

High fever

Seizures

Irregular heartbeat

Loss of consciousness

Zofran Recall

More than a year after the FDA first warned about Zofran side effects, the agency recalled 32-mg intravenous Zofran in December 2012. Results were published in Reproductive Toxicology.

Another recent study, published by BioMed Research International in December 2013 by Australian researchers, linked the use of Zofran in the first trimester with a non-significant 20% increased risk of birth defects and higher rates of kidney defects. Food and Drug Administration (FDA), and is now available as a generic medication called Onsandestron. Zofran works by inhibiting 5-HT3 serotonin receptors.

Zofran is primarily prescribed to treat nausea and vomiting in patients undergoing chemotherapy. If you or somebody you know has been injured by Zofran, you should contact our lawyers immediately for a free case consultation. This can cause a disorder called QT interval prolongation, in which the electrical charge in the heart takes longer than 440 milliseconds to recover between each beat. Unfortunately, this is a critical time in fetal development when many birth defects can occur.

Zofran is not approved by the FDA for morning sickness and it is “Pregnancy Class B,” which means placebo-controlled studies have only been conducted in animals. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

. The drug can interfere with electrical activity in the heart, which may cause a fatal irregular heart rhythm disorder. However, 50% of the women took Zofran after the first trimester, when their baby was no longer at risk of many birth defects.

More recently, an investigative report by the Toronto Star found nearly two dozen case reports linking Zofran with heart defects, kidney problems, musculoskeletal abnormalities, and other birth defects.

In December 2014, Swedish researchers looked at data on 1,400 Zofran-exposed pregnancies from 1998-2012 and found that Zofran doubled the risk of septal heart defects. The heart may flutter ineffectively and suddenly stop beating. Cardiovascular side effects of Zofran may include:

Chest pain, tightness, or discomfort

Irregular heart rhythm

Abnormally fast, slow, or weak pulse

QT interval prolongation

Torsades de Pointes

Ventricular arrhythmia

Zofran is also associated with the following serious side effects:

Muscle weakness

Fatigue

Dizziness

Headaches

Allergic reaction

Swelling of the face, lips, tongue

Fever

Diarrhea

Constipation

And more

Cardiovascular Zofran Side Effects

Zofran can interfere with electrical activity in the heart

Hana Biosciences Successfully Completes Pivotal Trials of Zensana(TM), First Proprietary Ondansetron Oral Spray for Chemotherapy-Induced Nausea and Vomiting

Details of these results will be presented on June 3, 2006 at the ASCO Annual Meeting.

— Zensana(TM) (ondansetron oral spray) delivers detectible ondansetron levels statistically faster than oral Zofran(R) tablets. Data from the 4 studies, referred to as ZOOS I-IV, respectively, reaffirm that Zensana(TM) 8 mg dose is statistically bioequivalent to the current commercially available 8 mg ondansetron (Zofran(R)) tablet, and can be conveniently administered in multiple doses.

— Completion of 4 registrational clinical studies, ZOOS I-IV (Zensana(TM) Ondansetron Oral Spray), allows for NDA (new drug application) submission under section 505(b)(2) in 2006. Drug delivery via a spray to the oral mucosa avoids degradation in the gastrointestinal tract and metabolism by liver enzymes — the so-called first-pass effect. In the 4 studies, Zensana(TM) was well tolerated by both men and women and did not result in any unexpected adverse events.

— Hana targets Zensana(TM) for US commercial launch in 2007. Other risks that may affect forward-looking information contained in this press release include the possibility of being unable to obtain regulatory approval of Hana’s product candidates, the risk that the results of clinical trials may not support Hana’s claims, Hana’s reliance on third-party researchers to develop its product candidates, and its lack of experience in developing pharmaceutical products.

The Zensana(TM) clinical development program, consisting of 4 clinical studies including single and multiple dose pharmacokinetic studies, and evaluation of the effects of food and water on Zensana(TM), are now complete. Zensana(TM) delivered statistically faster absorption as defined by median time to detectible drug levels of ondansetron at 15 minutes versus the tablet at 30 minutes.

Patients experiencing nausea and vomiting have difficulty swallowing and holding down pills. Zensana(TM) delivers full doses of ondansetron to patients receiving emetogenic chemotherapy.

Hana Biosciences, Inc. Ondansetron is approved to prevent chemotherapy and radiation-induced, and post-operative nausea and vomiting. Hana targets commercial launch of Zensana(TM) in 2007.

Hana acquired the exclusive rights to market the novel oral spray formulation in the US and Canada from NovaDel Pharma, Inc. Among other things, there can http://www.drugs.com/pro/zofran.html be no assurances that any of Hana’s development efforts relating to its product candidates will be successful. (AMEX:HBX) is a South San Francisco, CA-based biopharmaceutical company that acquires, develops, and commercializes innovative products to advance cancer care. Additional risks are described in the company’s Annual Report on Form 10-KSB for the year ended Dec. 31, 2004. Nausea and vomiting are the leading concerns of patients undergoing chemotherapy.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements.

About Chemotherapy-Induced Nausea and Vomiting

According to the National Cancer Institute over 500,000 Americans received chemotherapy in 2004, and the majority of these patients received an anti-emetic such as ondansetron.

“Zensana(TM) has promising market potential as a new, convenient alternative formulation for treating nausea and vomiting associated with chemotherapy which will help patients get on with their lives,” stated Mark Ahn, PhD, President and CEO. The company is committed to zofran settlements creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture. Hana assumes no obligation to update these statements, except as required by law.

.

With these clinical studies complete, Hana confirms its plan to submit a New Drug Application (NDA) in 2006, following a meeting with the FDA.

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–March 9, 2006–Hana Biosciences, Inc. Annual US sales for ondansetron were approximately $1.0 billion, representing a 66% market share among the four approved 5-HT3 products in 2004. Such statements involve risks and uncertainties that could cause Hana’s actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. “Our team is excited about establishing a focused and scalable commercial presence to serve oncologists which leverages the team’s development and marketing experience.”

About Zensana(TM) (Ondansetron Oral Spray)

Zensana(TM) (ondansetron oral spray) is the first multidose oral spray 5-HT3 antagonist. The company targets the US launch of Zensana(TM) in 2007. (AMEX:NVD).

Hana Biosciences (AMEX:HBX), a biopharmaceutical company focused on advancing cancer care, announced the successful completion of all clinical trials of Zensana(TM) (ondansetron oral spray) required for FDA registration under section 505(b)(2). Hana intends to file a New Drug Application (NDA) under section 505(b)(2), a form of registration that relies on data in previously approved NDAs and published literature. (AMEX:HBX):

— Positive pivotal studies confirm Zensana(TM) (ondansetron oral spray) 8 mg dose is statistically bioequivalent to the current commercially available 8 mg ondansetron (Zofran(R)) tablet. Additional information on Hana Biosciences can be found at http://www.hanabiosciences.com.

About Hana Biosciences, Inc

Will government ban my Endocet?

.

I don’t http://www.empr.com/zofran-injection/drug/1499/ think they are going to ban it but there is a pending challenge right now from the FDA. Like I said though I doubt it zofran birth defects statistics will be banned because the FDA does not seem like they are really considering enforcing the recall/Ban. The issue they are looking into is the paracetamol (Tylenol) content of the Endocet. The ban or rather recall that is being considered is not just Endocet but includes all analgesic (pain meds) that contain Tylenol, including Endocet, Percocet, Tylox, Vicodin, Lortab, Ultracet and many others

GlaxoSmithKline to plead guilty, pay $3B for illicit promotion of drugs in record settlement

WASHINGTON –  GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information on a third in the largest health care fraud settlement in U.S. history, the Justice Department said Monday.

Accompanying the criminal case was a civil settlement in which the government said the company’s improper marketing included providing doctors with expensive resort vacations, European hunting trips, high-paid speaking tours and even tickets to a Madonna concert.

The $3 billion combined criminal-civil fine will be the largest penalty ever paid by a drug company, Deputy Attorney General James M. Cole said. The corporation also agreed to be monitored by government officials for five years to attempt to ensure the company’s compliance, Cole said.

“Let me be clear, we will not tolerate health care fraud,” Cole told a zofran birth defects impartial opinion news conference at the Justice Department. He would not say whether any company executives were under investigation. The company’s guilty plea and sentence have to be approved by a federal court in Massachusetts.

“For far too long, we have heard that the pharmaceutical industry views these settlements merely as the cost of doing business,” Acting Assistant Attorney General Stuart F. Delery, head of Justice’s civil division, said at the news conference. “That is why this administration is committed to using every available tool to defeat health care fraud.”

Delery added, “Today’s resolution seeks not only to punish wrongdoing and recover taxpayer dollars, but to ensure GSK’s future compliance with the law.” He noted that a similar recent settlement with Abbott Laboratories also included continuing compliance monitoring.

GlaxoSmithKline CEO Sir Andrew Witty expressed regret and said they have learned “from the mistakes that were made.”

“Today brings to resolution difficult, long-standing matters for GSK,” he said in a statement. “Whilst these originate in a different era for the company, they cannot and will not be ignored.”

Crimes and civil violations like those in the GlaxoSmithKline case have been widespread in the pharmaceutical industry and have produced a series of case with hefty fines. One reason some have said the industry regards the fines as simply a cost of doing business is because aggressively promoting drugs to doctors for uses not officially approved — including inducing other doctors to praise the drugs to colleagues at meetings — has quickly turned numerous drugs from mediocre sellers into blockbusters, with more than $1 billion in annual sales.

In the last few years, the Justice Department has become much more aggressive in pursuing such fraud, often in whistleblower cases taken on by a handful of U.S. attorneys focused on such fraud. Among the most active are the U.S. attorneys in Boston, Philadelphia and San Francisco — all in regions with numerous pharmaceutical and biotech company operations.

The prior record-setting case involved Pfizer Inc., the world’s biggest drugmaker. Pfizer paid the government $2.3 billion in criminal and civil fines for improperly marketing 13 different drugs, including Viagra and cholesterol fighter Lipitor. Pfizer was accused of encouraging doctors to prescribe its drugs with free golf, massages, and junkets to posh resorts.

It is illegal to promote uses for a drug that have not been approved by the Food and Drug Administration — a practice known as off-label marketing.

Prosecutors said GlaxoSmithKline illegally promoted the drug Paxil for treating depression in children from April 1998 to August 2003, even though the FDA never approved it for anyone under age 18. The corporation also promoted the drug Wellbutrin from January 1999 to December 2003 for weight loss, the treatment of sexual dysfunction, substance addictions and attention deficit hyperactivity disorder, although it was only approved for treatment of major depressive disorder.

Justice Department officials also said that between 2001 and 2007 GlaxoSmithKline failed to report to the FDA on safety data from certain post-marketing studies and from two studies of the cardiovascular safety of the diabetes drug Avandia. Since 2007, the FDA has added warnings to the Avandia label to alert doctors about potential increased risk of congestive heart failure and heart attack.

The drug corporation also agreed to resolve civil liability for promoting the drugs Paxil, Wellbutrin, Advair, Lamictal and Zofran for off-label, non-covered uses. In the civil settlement, the government said Advair was promoted as a first-line therapy for mild asthma though not approved for that and for chronic obstructive pulmonary disease with misleading claims. It said the anti-epileptic medicine Lamictal was promoted for off-label psychiatric uses, neuropathic pain and pain management. And it said certain forms of Zofran, approved only for post-operative nausea, were promoted to treatment of morning sickness in pregnant women.

The company also resolved accusations that it paid kickbacks to doctors to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex.

“GSK’s sales force bribed physicians to prescribe GSK products using every imaginable form of high priced entertainment, from Hawaiian vacations to paying doctors millions of dollars to go on speaking tours to a European pheasant hunt to tickets to Madonna concerts, and this is just to name a few,” said Carmin M. Ortiz, U.S. attorney in Massachusetts.

Of the penalties, $1 billion covers criminal fines and http://www.schmidtlaw.com/zofran-lawsuits/ forfeitures and $2 billion is for civil settlements with the federal government and the state governments of Massachusetts and Colorado.

In a statement, GlaxoSmithKline said it disagreed with some statements the Justice Department made in court papers. For example, the company said its settlement with the government does “not constitute an admission of any liability or wrongdoing in the selling and marketing of Lamictal, Zofran, Imitrex, Lotronex, Flovent, Valtrex, Avandia or Advair products. The government also made allegations about Paxil, Wellbutrin that the company did not admit.”

“The civil settlement agreement contains many allegations that are either inaccurate or incomplete, that selectively tell only parts of the story, and that draw unwarranted conclusions from disputed facts,” the company said.